Logo image of NXE.CA

NEXGEN ENERGY LTD (NXE.CA) Stock Fundamental Analysis

TSX:NXE - Toronto Stock Exchange - CA65340P1062 - Common Stock - Currency: CAD

9.17  +0.11 (+1.21%)

Fundamental Rating

2

Taking everything into account, NXE scores 2 out of 10 in our fundamental rating. NXE was compared to 212 industry peers in the Oil, Gas & Consumable Fuels industry. NXE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. NXE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NXE had negative earnings in the past year.
In the past year NXE has reported a negative cash flow from operations.
In the past 5 years NXE reported 4 times negative net income.
NXE had a negative operating cash flow in each of the past 5 years.
NXE.CA Yearly Net Income VS EBIT VS OCF VS FCFNXE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

The Return On Assets of NXE (-5.99%) is worse than 61.32% of its industry peers.
NXE has a Return On Equity (-8.51%) which is in line with its industry peers.
Industry RankSector Rank
ROA -5.99%
ROE -8.51%
ROIC N/A
ROA(3y)-2.29%
ROA(5y)-11.88%
ROE(3y)-3.42%
ROE(5y)-30.84%
ROIC(3y)N/A
ROIC(5y)N/A
NXE.CA Yearly ROA, ROE, ROICNXE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

NXE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NXE.CA Yearly Profit, Operating, Gross MarginsNXE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

4

2. Health

2.1 Basic Checks

The number of shares outstanding for NXE has been increased compared to 1 year ago.
NXE has more shares outstanding than it did 5 years ago.
NXE has a worse debt/assets ratio than last year.
NXE.CA Yearly Shares OutstandingNXE.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
NXE.CA Yearly Total Debt VS Total AssetsNXE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 6.33 indicates that NXE is not in any danger for bankruptcy at the moment.
NXE's Altman-Z score of 6.33 is amongst the best of the industry. NXE outperforms 89.15% of its industry peers.
NXE has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.00, NXE belongs to the best of the industry, outperforming 82.55% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 6.33
ROIC/WACCN/A
WACCN/A
NXE.CA Yearly LT Debt VS Equity VS FCFNXE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 0.97 indicates that NXE may have some problems paying its short term obligations.
With a decent Current ratio value of 0.97, NXE is doing good in the industry, outperforming 60.85% of the companies in the same industry.
NXE has a Quick Ratio of 0.97. This is a bad value and indicates that NXE is not financially healthy enough and could expect problems in meeting its short term obligations.
NXE's Quick ratio of 0.97 is fine compared to the rest of the industry. NXE outperforms 66.51% of its industry peers.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.97
NXE.CA Yearly Current Assets VS Current LiabilitesNXE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 65.52% over the past year.
EPS 1Y (TTM)65.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%183.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, NXE will show a small growth in Earnings Per Share. The EPS will grow by 2.55% on average per year.
NXE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 210.01% yearly.
EPS Next Y33.41%
EPS Next 2Y11.51%
EPS Next 3Y-2.19%
EPS Next 5Y2.55%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y210.01%

3.3 Evolution

NXE.CA Yearly Revenue VS EstimatesNXE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2024 2028 2029 2030 2031 2032 1B 2B 3B
NXE.CA Yearly EPS VS EstimatesNXE.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -0.1 -0.2 -0.3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NXE. In the last year negative earnings were reported.
Also next year NXE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NXE.CA Price Earnings VS Forward Price EarningsNXE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NXE.CA Per share dataNXE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

NXE's earnings are expected to decrease with -2.19% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.51%
EPS Next 3Y-2.19%

More info and screens

0

5. Dividend

5.1 Amount

NXE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEXGEN ENERGY LTD

TSX:NXE (6/23/2025, 7:00:00 PM)

9.17

+0.11 (+1.21%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-12 2025-05-12/amc
Earnings (Next)08-05 2025-08-05/bmo
Inst Owners54.47%
Inst Owner ChangeN/A
Ins Owners4.54%
Ins Owner ChangeN/A
Market Cap5.22B
Analysts81.11
Price Target13.59 (48.2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)41.07%
Min EPS beat(2)-159.31%
Max EPS beat(2)241.44%
EPS beat(4)3
Avg EPS beat(4)46.25%
Min EPS beat(4)-159.31%
Max EPS beat(4)241.44%
EPS beat(8)3
Avg EPS beat(8)-51.8%
EPS beat(12)4
Avg EPS beat(12)-131.16%
EPS beat(16)4
Avg EPS beat(16)-158.46%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.41%
PT rev (3m)-5.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.94%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.07%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.73
P/tB 4.73
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS1.94
TBVpS1.94
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.99%
ROE -8.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-2.29%
ROA(5y)-11.88%
ROE(3y)-3.42%
ROE(5y)-30.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5461.66%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.97
Quick Ratio 0.97
Altman-Z 6.33
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)5324.66%
Cap/Depr(5y)3796.13%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%183.33%
EPS Next Y33.41%
EPS Next 2Y11.51%
EPS Next 3Y-2.19%
EPS Next 5Y2.55%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y210.01%
EBIT growth 1Y45.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-2.72%
EBIT Next 3Y3.55%
EBIT Next 5Y9.69%
FCF growth 1Y-41.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.5%
OCF growth 3YN/A
OCF growth 5YN/A